Connect Biopharma Holdings (CNTB) Earnings Date & Reports
Connect Biopharma Holdings Ltd is a clinical-stage biopharmaceutical company dedicated to transforming care for asthma and chronic obstructive pulmonary disease (COPD)... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
CNTB is expected to report earnings to fall 7.79% to -213 cents per share on September 15
Q2'26
Est.
$-2.13
Q1'26
Missed
by $2.07
Q4'25
Beat
by $1.84
Q3'25
Beat
by $1.80
Q2'25
Beat
by $1.73
The last earnings report on May 12 showed earnings per share of -230 cents, missing the estimate of -23 cents. With 173.61K shares outstanding, the current market capitalization sits at 133.48M.